SCHEMBL7239292

SCHEMBL7239292

CC(Nc1cccnc1)=C1C(=O)Nc2ccc(N)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 5/20 0.43
AKT2 P31751 3/20 0.43
ALDH1A1 P00352 1/20 0.40
HTT P42858 1/20 0.40
AKT1 P31749 1/20 0.40
WNT1 P04628 1/20 0.39
DYRK1A Q13627 1/20 0.39
NPC1 O15118 5/20 0.38
RAB9A P51151 5/20 0.38
NAMPT P43490 1/20 0.38
MAPT P10636 2/20 0.38
CASP3 P42574 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
TGM2 P21980 1/20 0.38
PRKCI P41743 1/20 0.38
PKM P14618 1/20 0.37
RPS6KA3 P51812 1/20 0.37
LMNA P02545 1/20 0.37
BRD4 O60885 1/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7239288 1.00 PDPK1 (0.43) PDPK1AKT2ALDH1A1HTTAKT1
SCHEMBL7086337 0.86 NAMPT (0.44) PDPK1AKT2ALDH1A1HTTNPC1
SCHEMBL7086341 0.86 NAMPT (0.44) PDPK1AKT2ALDH1A1HTTNPC1
SCHEMBL7244960 0.86 PDPK1 (0.44) PDPK1AKT2ALDH1A1AKT1RPS6KA3
SCHEMBL7244956 0.86 PDPK1 (0.44) PDPK1AKT2ALDH1A1AKT1RPS6KA3
SCHEMBL7241363 0.83 HIF1A (0.42) PDPK1AKT2AKT1WNT1DYRK1A
SCHEMBL7241361 0.83 HIF1A (0.42) PDPK1AKT2AKT1WNT1DYRK1A
SCHEMBL7238182 0.81 PDPK1 (0.39) PDPK1AKT2AKT1BRD4
SCHEMBL7238189 0.81 PDPK1 (0.39) PDPK1AKT2AKT1BRD4
SCHEMBL7246566 0.81 KDR (0.47) PDPK1AKT2ALDH1A1HTTAKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545035-B1 Having effect on various kinases and cycline/CDK complexes and on the proliferation of various tumour cells. BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-04-08 US disclosed
US-6319918-B1 FOR LYMPHOMA OR SOLID TUMORS TREATMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-11-20 US disclosed
EP-1100779-A1 SUBSTITUTED INDOLINONES, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS Boehringer Ingelheim Pharma KG (DE) 2001-05-23 EP disclosed
WO-1999062882-A1 SUBSTITUTED INDOLINONES, THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-12-09 WO disclosed